Health and Life Sciences icon

Can the UK innovate its way beyond the frictions? The case of clinical trials regulations

Health and Life Sciences

Rachel Lygoe

At the start of this year, the UK Medicines and Healthcare products Regulatory Agency (MHRA) launched a consultation on its proposals for legislative changes to clinical trials. The consultation marks the latest in a series of efforts to reform the UK’s life sciences regulatory landscape post-Brexit and create a “world-class sovereign regulatory environment for clinical…

Read more